Published in
Taylor and Francis Group, Journal of Medical Economics (JME), 10(22), p. 997-1005, 2019
DOI: 10.1080/13696998.2019.1614009
Links
Tools
Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden
Journal article published in 2019 by
Åsa Ericsson,
Adam Fridhammar 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 